参考文献/References:
[1] VERMEERSCH K, GABROVSKA M, AUMANN J,et al. Azithromycin during acute chronic obstructivepulmonary disease exacerbat ions requi r inghospitalization (BACE). A multicenter, randomized,double-blind, placebo-controlled trial[J]. AmericanJournal of Respiratory and Critical Care Medicine,2019, 200(7): 857-868.
[2] PISANI L, ASTUTO M, PREDILETTO I, et al. Highflow through nasal cannula in exacerbated COPDpatients: a systematic review[J]. Pulmonology, 2019,25(6): 348-354.
[3] WANG Chen, XU Jianying, YANG Lan, et al.Prevalence and risk factors of chronic obstructivepulmonary disease in China (the China PulmonaryHealth [CPH] study): a National cross-sectionalstudy[J]. Lancet, 2018, 391(1131): 1706-1717.
[4] QI Yujing, SUN Xuejiao, WANG Zhe, et al. Richnessof sputum microbiome in acute exacerbations ofeosinophilic chronic obstructive pulmonary disease[J].Chinese Medical Journal（English）, 2020, 133(5):542-551.
[5] R?O RAM?REZ M T, JURETSCHKE MORAGUESM A ，FERN?NDEZ GONZ?LEZ R, et al. Value ofexhaled nitric oxide (FeNO) and eosinophilia during theexacerbations of chronic obstructive pulmonary diseaserequiring hospital admission[J]. COPD: Journal ofChronic Obstructive Pulmonary Disease, 2018, 15(4):369-376.
[6] 李星虹, 李振生, 王红景, 等. 呼出气一氧化氮及嗜酸粒细胞预测COPD 患者吸入型糖皮质激素治疗效果的临床价值[J]. 国际呼吸杂志,2019,39(12):916-920.LI Xinghong，LI Zhensheng，WANG Hongjing，etal. Clinical value in predicting inhaled corticosteroidseffect of fractional exhaled nitric oxide and eosnophilfor COPD patients[J]. International Journal of Respiration,2019,39(12):916-920.
[7] 张勃，白吉明，王少飞，等．戒烟对COPD 患者肺功能、CAT 评分和急性发作的影响[J]. 重庆医学,2019,48(9):1527-1530.ZHANG Bo，BAI Jiming，WANG Shaofei，et al.The effect of smoking cessation on pulmonary function,CAT scores and exacerbations in COPD patients[J].Chongqing Medicine,2019,48(9):1527-1530.
[8] 陈亚红, 王辰.2015 新版GOLD COPD 指南摘译和解读[J]. 中国医学前沿杂志( 电子版)，2015,7(2): 34-39.CHEN Yahong,WANG Chen. Excerpt and interpretationof the 2015 gold COPD guidelines[J].Chinese Journalof the Frontiers of Medical Science (ElectronicVersion),2015,7(2):34-39.
[9] DREHER M, DAHER A, KESZEI A, et al. Wholebodyplethysmography and blood gas analysis inpatients with acute myocardial infarction undergoingpercutaneous coronary intervention[J]. Respiration;International Review of Thoracic Diseases, 2019, 97(1):24-33.
[10] AVDEEV S, TRUSCHENKO N V, GAYNITDINOVAV V, et al. Treatment of exacerbations of chronicobstructive pulmonary disease [J]. TerapevticheskiiArkhiv, 2018, 90(12):68-75.
[11] 刘俊强．慢性阻塞性肺疾病患者CT 血管成像结果与肺功能参数、血气分析结果的相关性分析[J]．中国卫生检验杂志，2018，28（3）：313-316．LIU Junqiang. Correlation analysis of CT angiographyresults with pulmonary function parameters and bloodgas analysis result in patients with chronic obstructivepulmonary disease[J]. Chinese Journal of HealthLaboratory Technology,2018,28(3):313-316.
[12] SPECE L J, DONOVAN L M, GRIFFITH M F, etal. Quality of care delivered to veterans with COPDexacerbation and the association with 30-Dayreadmission and death[J]. COPD: Journal of ChronicObstructive Pulmonary Disease, 2018, 15(5): 489-495.
[13] SAMAREH FEKRI M, TORABI M, AZIZI SHOUL S,et al. Prevalence and predictors associated with severepulmonary hypertension in COPD[J]. The AmericanJournal of Emergency Medicine, 2018, 36(2): 277-280.
[14] 陈杰, 孙耕耘. 慢性阻塞性肺疾病频繁加重的多因素分析[J]. 中华疾病控制杂志,2019,23(3):341-344.CHEN Jie,SUN Gengyun. Analysis of the indicators offrequent exacerbation of chronic obstructive pulmonarydisease [J].Chinese Journal of Disease Control &Prevention, 2019,23(3):341-344.
[15] HOILAND R L, MLADINOV S, BARAK O F, et al.Oxygen therapy improves cerebral oxygen deliveryand neurovascular function in hypoxaemic chronicobstructive pulmonary disease patients[J]. ExperimentalPhysiology, 2018, 103(8): 1170-1177.
[16] MOSTAFAVI-POUR-MANSHADI S M, NADERI N,BARRECHEGUREN M, et al. Investigating fractionalexhaled nitric oxide in chronic obstructive pulmonarydisease (COPD) and Asthma-COPD overlap (ACO):A scoping review[J]. Journal of Chronic ObstructivePulmonary Disease, 2018, 15(4): 377-391.
[17] KAVATI A, ZHDANAVA M, ORTIZ B, et al.Retrospective study on the association of biomarkerswith real-world outcomes of omalizumab-treatedpatients with allergic asthma[J]. Clinical Therapeutics,2019, 41(10): 1956-1971.
[18] 李玉磊，陈国忠，刘莉敏，等．慢性阻塞性肺疾病患者呼出气一氧化氮与外周血嗜酸性粒细胞相关性分析[J]. 实用医学杂志,2018,34(21):3521-3524.LI Yulei,CHEN Guozhong,LIU Limin,et al. Therelationship of fractional exhaled nitric oxide andperipheral blood eosinophils[J]. The Journal of PracticalMedicine,2018,34(21):3521-3524.
[19] AHN S, KIM T O, CHANG Jinsun, et al. Clinicalfeatures of chronic obstructive pulmonary disease withhigh fractional exhaled nitric oxide[J]. Tuberculosis andRespiratory Diseases, 2020, 83(3): 234-241.
[20] KARLOH M, VIEIRA ROCHA S A, MENEZESPIZZICHINI M M, et al. Is the COPD assessmenttest sensitive for differentiating COPD patients fromactive smokers and nonsmokers without lung functionimpairment? a population-based study[J]. JornalBrasileiro de Pneumologia, 2018, 44(3): 213-219.
[21] SHEN Meidi, LI Yuewei, DING Xiangdong, et al. Effectof active cycle of breathing techniques in patients with chronic obstructive pulmonary disease: a systematicreview of intervention[J]. European Journal of Physicaland Rehabilitation Medicine, 2020, 56(5): 625-632.
[22] 毛彦华，曹卫军．COPD 稳定期血EOS% 与FeNO测定对糖皮质激素疗效的预测价值分析[J]. 中国医师杂志,2020,22(2):254-257, 262.MAO Yanhua，CAO Weijun. The predictive value ofserum EOS % and FeNO in stable phase of COPD forthe therapeutic effect of glucocorticoids[J]. Journal ofChinese Physician,2020,22(2):254-257, 262.
[23] 韩曙光, 刘玲, 冯金萍, 等. 血清HMGB1，IL-27 水平及CAT 评分与COPD 合并Ⅱ型呼吸衰竭的关系分析[J]. 国际呼吸杂志,2019,39(17):1297-1301.HAN Shuguang,LIU Ling,FENG Jinping,et al. Relationshipbetween serum HMGB1 and IL-27 levels, CAT scoreand COPD with typeⅡ respiratory failure [J]. InternationalJournal of Respiration,2019,39(17):1297-1301.
相似文献/References:
[1]邱淑佳.慢性阻塞性肺疾病患者血清LCN1,LCN2的表达水平及临床意义[J].现代检验医学杂志,2017,32(06):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
QIU Shu-jia.Expression Levels of Serum LCN1 and LCN2
in Patients with Acute Exacerbation of Chronic Obstructive
Pulmonary Disease and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(04):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[2]杜 洁a,朱 娜b,李红艳a,等.幽门螺杆菌感染对慢性阻塞性肺疾病血气分析及肺功能的影响[J].现代检验医学杂志,2017,32(06):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
DU Jiea,ZHU Nab,LI Hong-yana,et al.Effect of Helicobacter Pylori Infection
on Blood Gas Analysis and Pulmonary Function
in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2017,32(04):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[3]李若倩,刘 云,李若然.外周血红细胞分布宽度和超敏C- 反应蛋白水平检测在慢性阻塞性肺疾病诊断中的价值分析[J].现代检验医学杂志,2020,35(03):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
LI Ruo-qian,LIU Yun,LI Ruo-ran.Value of Detecting Peripheral Blood Red Blood Cell Distribution Width and
High Sensitivity C Reactive Protein in the Diagnosis of Chromic
Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2020,35(04):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
[4]陈元菁,艾红军,王湘云,等.COPD 患者线粒体功能及代谢水平变化检测与骨骼肌功能障碍的相关性研究[J].现代检验医学杂志,2020,35(06):25.[doi:doi:10.3969/j.issn.1671-7414.2020.06.007]
CHEN Yuan-jing,AI Hong-jun,WANG Xiang-yun,et al.Study on the Correlation between Changes Detection in Mitochondrial Function,Metabolic Level and Skeletal Muscle Dysfunction Inpatients with COPD[J].Journal of Modern Laboratory Medicine,2020,35(04):25.[doi:doi:10.3969/j.issn.1671-7414.2020.06.007]
[5]王 苗,张 萍.COPD患者血清 Cav-1及 CXCL12水平检测与并发肺动脉高压的相关性研究[J].现代检验医学杂志,2021,36(01):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
WANG Miao,ZHANG Ping.Correlation between Levels of Cav-1 and CXCL12 in Serum and Pulmonary Hypertension in Patients with COPD[J].Journal of Modern Laboratory Medicine,2021,36(04):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
[6]闫海燕,杨云秀,杨云华,等.慢性阻塞性肺疾病患者 Nrf2 基因多态性与肺功能及临床病情判断的相关性研究[J].现代检验医学杂志,2021,36(03):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
YAN Hai-yan,YANG Yun-xiu,YANG Yun-hua,et al.Study on Relevance of Nrf2 Gene Polymorphism with Pulmonary Functionand Clinical Condition Judgment in Patients with Chronic ObstructivePulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(04):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
[7]胡小燕,郑 晓,嵇华夏,等.血清 PCT 与 BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J].现代检验医学杂志,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
HU Xiao-yan,ZHENG Xiao,JI Hua-xia,et al.Clinical Diagnostic Value of Combined Detection of Serum PCT and BNPLevels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(04):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
[8]陈志勇a,罗世林a,张 健b,等.慢阻肺患者血清IL-17，IL-27和IL-33水平表达及与不同临床分期FeNO和肺功能的相关性研究[J].现代检验医学杂志,2021,36(04):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
CHEN Zhi-yonga,LUO Shi-lina,ZHANG Jianb,et al.Expression of Serum IL-17, IL-27 and IL-33 in Patients with ChronicObstructive Pulmonary Disease and Its Correlation with FeNO and LungFunction in Different Clinical Stages[J].Journal of Modern Laboratory Medicine,2021,36(04):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
[9]龙借帆a,李 翠a,高元标a,等.联合检测血清SIRT1和CTRP5水平对慢性阻塞性肺疾病急性加重期患者预后的预测价值研究[J].现代检验医学杂志,2022,37(03):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]
LONG Jie-fana,LI Cuia,GAO Yuan-biaoa,et al.Prognostic Value of Combined Detection of Serum SIRT1 and CTRP5 Levels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2022,37(04):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]
[10]孙 澜,马吉芳,崔乃凡.慢性阻塞性肺疾病并发肺动脉高压患者血清CCL28，SDF-1 表达水平及临床意义[J].现代检验医学杂志,2023,38(01):140.[doi:10.3969/j.issn.1671-7414.2023.01.026]
SUN Lan,MA Ji-fang,CUI Nai-fan.Expression of Serum CCL28 and SDF-1 in Patients with Chronic Obstructive Pulmonary Disease Complicated by Pulmonary Hypertension and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2023,38(04):140.[doi:10.3969/j.issn.1671-7414.2023.01.026]